With miraculix, we have succeeded in developing simple substance tests, which for the first time can be used to determine the concentration of the active substances LSD, MDMA, and psilocybin from "magic mushrooms" in an uncomplicated and mobile way. We aim to make decision-relevant information available to everyone, thus minimizing risks and saving lives.